BioNexus Gene Lab (BGLC) Operating Margin (2018 - 2026)
BioNexus Gene Lab recorded quarterly Operating Margin of 2366.21% in Q1 2026, down 1008.28% quarter-over-quarter from 213.5% in Q4 2025, and down 233727.0% year-over-year from N/an in Q1 2025.
BioNexus Gene Lab's Operating Margin history runs 9 years deep, the most recent figure standing at 2366.21% for Q1 2026.
- In Q1 2026, Operating Margin fell 233727.0% year-over-year to 2366.21%; the TTM figure through Mar 2026 stood at 54.36% (down 3156.0% YoY), while the FY2025 annual figure was 39.93%, down 2339.0% from the prior year.
- Operating Margin came in at 2366.21% for Q1 2026 at BioNexus Gene Lab, down from 213.5% in the prior quarter.
- In the past five years, Operating Margin ranged from a high of 13.13% in Q2 2024 to a low of 2366.21% in Q1 2026.
- A 5-year average of 166.62% and a median of 10.6% in 2023 frame the typical range for Operating Margin.
- Across the five-year window, Operating Margin surged 4816 bps in 2024 and plunged 233727 bps in 2026, its largest moves.
- BioNexus Gene Lab's Operating Margin stood at 4.32% in 2022, then soared by 362 bps to 11.34% in 2023, then plunged by 245 bps to 16.49% in 2024, then tumbled by 1195 bps to 213.5% in 2025, then slumped by 1008 bps to 2366.21% in 2026.
- According to Business Quant data, Operating Margin over the past three periods registered 2366.21%, 213.5%, and 27.62% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Linde | 230.79 Bn | 226.84 Bn | 4.26 Bn | 27.78% |
| 2 | Chemical & Mining Co Of Chile | 127.66 Bn | 124.93 Bn | 778.60 Mn | 47.01% |
| 3 | Sherwin Williams | 72.51 Bn | 72.30 Bn | 2.78 Bn | 14.31% |
| 4 | Ecolab | 70.96 Bn | 70.34 Bn | 1.85 Bn | 16.97% |
| 5 | Air Products & Chemicals | 62.15 Bn | 63.70 Bn | 987.40 Mn | 23.73% |
| 6 | Ppg Industries | 25.04 Bn | 23.57 Bn | 1.66 Bn | 14.05% |
| 7 | LyondellBasell Industries | 21.62 Bn | 21.73 Bn | 701.00 Mn | 3.32% |
| 8 | Albemarle | 20.26 Bn | 19.42 Bn | 500.97 Mn | 35.06% |
| 9 | DuPont de Nemours | 19.45 Bn | 19.56 Bn | 602.00 Mn | 17.85% |
| 10 | BioNexus Gene Lab | 5.34 Mn | 1.38 Mn | -790.00 | -2,366.21% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2,366.21% |
| Dec 31, 2025 | -213.50% |
| Sep 30, 2025 | -27.62% |
| Jun 30, 2025 | -27.05% |
| Mar 31, 2025 | -28.94% |
| Dec 31, 2024 | -16.49% |
| Sep 30, 2024 | -50.85% |
| Jun 30, 2024 | 13.13% |
| Mar 31, 2024 | -3.32% |
| Dec 31, 2023 | 11.34% |
| Sep 30, 2023 | -99.01% |
| Jun 30, 2023 | -10.60% |
| Mar 31, 2023 | -2.13% |
| Dec 31, 2022 | -4.32% |
| Sep 30, 2022 | -2.53% |
| Jun 30, 2022 | -5.55% |
| Mar 31, 2022 | 1.15% |
| Dec 31, 2021 | 6.20% |
| Sep 30, 2021 | 10.42% |
| Jun 30, 2021 | 4.53% |
| Mar 31, 2021 | 9.92% |
| Dec 31, 2020 | -0.07% |
| Sep 30, 2020 | 7.68% |
| Jun 30, 2020 | -3.08% |
| Mar 31, 2020 | 34.97% |
| Dec 31, 2019 | -181.24% |
| Sep 30, 2019 | -207.41% |
| Jun 30, 2019 | -319.79% |
| Mar 31, 2019 | -214.34% |
| Dec 31, 2018 | -673.39% |
| Sep 30, 2018 | -60.18% |